Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Pulse Biosciences Inc fell by 16.77m. Cash Flow from Financing totalled 16.39m or -- of revenues. In addition the company used 33.04m for operations while cash used for investing totalled 121.00k.
Cash flow per share | -0.7865 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.29 |
---|---|
Tangible book value per share | 1.22 |
More ▼
Balance sheet in USDView more
Current ratio | 11.93 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼